AI-assisted, human-published
11/20/2024 /Funding Events
Valora Therapeutics Secures Seed Funding for Innovative Immunotherapy Approach
Valora Therapeutics Inc. closes seed funding round to advance AbLec platform targeting glyco-immune checkpoints, with potential applications in oncology and autoimmune diseases.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com